01789.HK
AK Medical Holdings Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 4.87
+0.52%Year over year
Reported trailing growth
- Revenue
- +12.2%
- EBITDA
- +33.2%
- EBIT
- +35.3%
- EPS
- +30.8%
- Free cash flow
- -52.9%
- Operating cash flow
- -60.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.1%
- EBITDA
- +13.0%
- EBIT
- +19.3%
- Net income
- +18.3%
- EPS
- +18.6%
- Free cash flow
- +37.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026